Find-A-Study

Home
About
Research Areas
Researchers
Clinical Trials

UT Health San Antonio

Home
About
Research Areas
Researchers
Clinical Trials

Study of the safety and effectiveness of Tecovirimat for the treatment of Human MonkeyPox Virus Disease (STOMP)

Contact The Study Team

To contact the study team, select:
Continue as Guest - to notify the team of your request without creating a profile.
Register - will allow you to create a profile that you can later reference and view all the studies you have inquired about.
Login - If you have already Registered, select Login.

Continue as Guest

Enter Your Contact Information

{{emailError}}

Comments

First Name

{{fNameError}}

Last Name

{{lNameError}}

Telephone #

Yes, I would like to be contacted about studies in the same category or cancer site

Privacy Notice: The data collected here will be used by UT Health San Antonio staff to contact you, either by email or by telephone, with the sole purpose of providing you with information regarding human study participation. You may be contacted in the future regarding studies similar to this one. Under no circumstances will we use your information for other purposes or share it with others. To the extent it is applicable, UT Health San Antonio complies with the General Data Protection Regulation (“GDPR”). Should you have any requests pertaining to your rights under the GDPR, please send it to: The IRB Reliance Team at irbreliance@uthscsa.edu | (210) 567-8555

Lay Description

To determine the difference in time to recovery and healing of monkey pox lesions between people receiving Tecovirimat and those receiving placebo. People with severe cases of monkeypox will receive Tecovirimat and not placebo.

Eligibility

Eligible Ages: 18-99
Eligible Genders: All
Accepts Healthy Volunteers

Inclusion Criteria

Illness < 14 days before study entry, have at least 1 active (not scabbed) lesion

Exclusion Criteria

Illness < 14 days before study entry, have at least 1 active (not scabbed) lesion

Study Design

Arm Groups

Study Contact

Contact The Study Team

Continue as Guest

Enter Your Contact Information

{{emailError}}

Comments

First Name

{{fNameError}}

Last Name

{{lNameError}}

Telephone #

Yes, I would like to be contacted about studies in the same category or cancer site

Irma Scholler
210-450-3150
scholler@uthscsa.edu

Principal Investigator
Thomas Patterson

UT Health San Antonio

8403 Floyd Curl Dr
San Antonio, TX 78229

210-567-8555
IRBreliance@uthscsa.edu

Connect with us

Job Opportunities
Research Directory
Mission Magazine
Give a Donation

We're a part of the UT Health Science Center San Antonio, provider of comprehensive patient care, advanced academics, and life-saving research.

Web Privacy | Links from websites affiliated with The University of Texas Health Science Center at San Antonio's website (uthscsa.edu) to other websites do not constitute or imply university endorsement of those sites, their content, or products and services associated with those sites. The content on this website is intended to be used for informational purposes only. Health information on this site is not meant to be used to diagnose or treat conditions. Consult a health care provider if you are in need of treatment.

Study of the safety and effectiveness of Tecovirimat for the treatment of Human MonkeyPox Virus Disease (STOMP)

Lay Description

Category

Eligibility

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups

Study Contact